Avecho Biotechnology Limited (AVE.AX)
AUD 0.0
(0.0%)
AUD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 941.54 Thousand AUD | 2.27% |
| 2022 | 920.65 Thousand AUD | 29.79% |
| 2021 | 709.35 Thousand AUD | 1.31% |
| 2020 | 700.16 Thousand AUD | 25.9% |
| 2019 | 556.12 Thousand AUD | -38.35% |
| 2018 | 902.04 Thousand AUD | -50.87% |
| 2017 | 1.83 Million AUD | 7.52% |
| 2016 | 1.7 Million AUD | -5.97% |
| 2015 | 1.81 Million AUD | -3.04% |
| 2014 | 1.87 Million AUD | -14.36% |
| 2013 | 2.18 Million AUD | 44.93% |
| 2012 | 1.5 Million AUD | -58.44% |
| 2011 | 3.63 Million AUD | -75.4% |
| 2010 | 14.76 Million AUD | -15.04% |
| 2009 | 17.37 Million AUD | -1.48% |
| 2008 | 17.63 Million AUD | -53.29% |
| 2007 | 37.75 Million AUD | -0.69% |
| 2006 | 38.02 Million AUD | -2.35% |
| 2005 | 38.93 Million AUD | 4702.46% |
| 2004 | 810.73 Thousand AUD | 3127.69% |
| 2003 | 25.11 Thousand AUD | -17.24% |
| 2002 | 30.35 Thousand AUD | -46.21% |
| 2001 | 56.41 Thousand AUD | -69.54% |
| 2000 | 185.25 Thousand AUD | 156.71% |
| 1999 | 72.16 Thousand AUD | 117.59% |
| 1998 | 33.16 Thousand AUD | -54.87% |
| 1997 | 73.48 Thousand AUD | -98.74% |
| 1996 | 5.83 Million AUD | 4.6% |
| 1995 | 5.57 Million AUD | 1368.16% |
| 1994 | 380 Thousand AUD | -73.95% |
| 1993 | 1.45 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.64 Million AUD | 0.0% |
| 2023 FY | 941.54 Thousand AUD | 2.27% |
| 2023 Q2 | 1.72 Million AUD | 0.0% |
| 2023 Q4 | 941.54 Thousand AUD | 0.0% |
| 2022 Q2 | 595.67 Thousand AUD | 0.0% |
| 2022 FY | 920.65 Thousand AUD | 29.79% |
| 2022 Q4 | 920.65 Thousand AUD | 0.0% |
| 2021 Q4 | 709.35 Thousand AUD | 0.0% |
| 2021 FY | 709.35 Thousand AUD | 1.31% |
| 2021 Q2 | 651.16 Thousand AUD | 0.0% |
| 2020 Q2 | 502.8 Thousand AUD | 0.0% |
| 2020 FY | 700.16 Thousand AUD | 25.9% |
| 2020 Q4 | 700.16 Thousand AUD | 0.0% |
| 2019 Q4 | 556.12 Thousand AUD | 0.0% |
| 2019 FY | 556.12 Thousand AUD | -38.35% |
| 2019 Q2 | 685.01 Thousand AUD | 0.0% |
| 2018 Q2 | 733.4 Thousand AUD | 0.0% |
| 2018 FY | 902.04 Thousand AUD | -50.87% |
| 2018 Q4 | 902.04 Thousand AUD | 0.0% |
| 2017 Q4 | 1.83 Million AUD | 0.0% |
| 2017 FY | 1.83 Million AUD | 7.52% |
| 2017 Q2 | 1.46 Million AUD | 0.0% |
| 2016 Q2 | 1.72 Million AUD | 0.0% |
| 2016 Q4 | 1.7 Million AUD | 0.0% |
| 2016 FY | 1.7 Million AUD | -5.97% |
| 2015 FY | 1.81 Million AUD | -3.04% |
| 2015 Q2 | 1.54 Million AUD | 0.0% |
| 2015 Q4 | 1.81 Million AUD | 0.0% |
| 2014 FY | 1.87 Million AUD | -14.36% |
| 2014 Q2 | 1.33 Million AUD | 0.0% |
| 2014 Q4 | 1.87 Million AUD | 0.0% |
| 2013 Q2 | 2.23 Million AUD | 0.0% |
| 2013 FY | 2.18 Million AUD | 44.93% |
| 2013 Q4 | 2.18 Million AUD | 0.0% |
| 2012 Q4 | 1.5 Million AUD | 0.0% |
| 2012 FY | 1.5 Million AUD | -58.44% |
| 2011 FY | 3.63 Million AUD | -75.4% |
| 2011 Q4 | 3.63 Million AUD | 0.0% |
| 2010 Q4 | 14.76 Million AUD | 0.0% |
| 2010 FY | 14.76 Million AUD | -15.04% |
| 2009 Q4 | 17.37 Million AUD | 0.0% |
| 2009 FY | 17.37 Million AUD | -1.48% |
| 2008 FY | 17.63 Million AUD | -53.29% |
| 2008 Q4 | 17.63 Million AUD | 0.0% |
| 2007 Q4 | 37.75 Million AUD | 0.0% |
| 2007 FY | 37.75 Million AUD | -0.69% |
| 2006 Q4 | 38.02 Million AUD | 0.0% |
| 2006 FY | 38.02 Million AUD | -2.35% |
| 2005 FY | 38.93 Million AUD | 4702.46% |
| 2005 Q4 | 38.93 Million AUD | 0.0% |
| 2004 Q4 | 810.73 Thousand AUD | 0.0% |
| 2004 FY | 810.73 Thousand AUD | 3127.69% |
| 2003 FY | 25.11 Thousand AUD | -17.24% |
| 2003 Q4 | 25.11 Thousand AUD | 0.0% |
| 2002 FY | 30.35 Thousand AUD | -46.21% |
| 2002 Q4 | 30.35 Thousand AUD | 0.0% |
| 2001 Q4 | 56.41 Thousand AUD | 0.0% |
| 2001 FY | 56.41 Thousand AUD | -69.54% |
| 2000 FY | 185.25 Thousand AUD | 156.71% |
| 2000 Q4 | 185.25 Thousand AUD | 0.0% |
| 1999 Q4 | 72.16 Thousand AUD | 0.0% |
| 1999 FY | 72.16 Thousand AUD | 117.59% |
| 1998 FY | 33.16 Thousand AUD | -54.87% |
| 1998 Q4 | 33.16 Thousand AUD | 0.0% |
| 1997 Q4 | 73.48 Thousand AUD | 0.0% |
| 1997 FY | 73.48 Thousand AUD | -98.74% |
| 1996 FY | 5.83 Million AUD | 4.6% |
| 1995 FY | 5.57 Million AUD | 1368.16% |
| 1994 FY | 380 Thousand AUD | -73.95% |
| 1993 FY | 1.45 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 4.22 Million AUD | 77.737% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -206.841% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 89.937% |
| Biome Australia Limited | 5.37 Million AUD | 82.477% |
| Patrys Limited | 691.36 Thousand AUD | -36.186% |
| Orthocell Limited | 22.08 Million AUD | 95.736% |
| Imugene Limited | 33.14 Million AUD | 97.159% |
| Noxopharm Limited | 1.28 Million AUD | 26.934% |
| PYC Therapeutics Limited | 10.18 Million AUD | 90.755% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 92.646% |
| Prescient Therapeutics Limited | 2.32 Million AUD | 59.513% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | 42.092% |
| Cynata Therapeutics Limited | 1.17 Million AUD | 19.599% |
| CSL Limited | 27.88 Billion AUD | 99.997% |
| Arovella Therapeutics Limited | 2.05 Million AUD | 54.219% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -155.544% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 96.651% |
| Starpharma Holdings Limited | 8.69 Million AUD | 89.175% |
| Nanollose Limited | 465.64 Thousand AUD | -102.202% |
| Memphasys Limited | 5.59 Million AUD | 83.164% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -118.136% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -998.864% |
| Amplia Therapeutics Limited | 3.42 Million AUD | 72.524% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | 74.772% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | 9.954% |
| Race Oncology Limited | 1.91 Million AUD | 50.87% |
| Nyrada Inc. | 855.63 Thousand AUD | -10.04% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 99.622% |
| Dimerix Limited | 13.89 Million AUD | 93.223% |
| PharmAust Limited | 896.6 Thousand AUD | -5.011% |
| Immutep Limited | 10.97 Million AUD | 91.425% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 88.699% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 82.647% |
| BTC Health Limited | 203.94 Thousand AUD | -361.657% |
| Acrux Limited | 5.68 Million AUD | 83.444% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 97.798% |
| Biotron Limited | 737.5 Thousand AUD | -27.665% |
| Tissue Repair Ltd | 1.35 Million AUD | 30.303% |
| AdAlta Limited | 3.54 Million AUD | 73.422% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 97.893% |
| Hexima Limited | 248.67 Thousand AUD | -278.63% |
| AnteoTech Limited | 4.07 Million AUD | 76.896% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | 73.732% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 94.076% |
| Actinogen Medical Limited | 1.61 Million AUD | 41.714% |
| Immuron Limited | 2.84 Million AUD | 66.853% |
| Argenica Therapeutics Limited | 2.42 Million AUD | 61.201% |